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Abstract
The evolution of drug resistant bacteria is a severe public health problem, both in hospitals and in the community.
Currently, some countries aim at concentrating highly specialized services in large hospitals in order to improve patient
outcomes. Emergent resistant strains often originate in health care facilities, but it is unknown to what extent hospital size
affects resistance evolution and the resulting spillover of hospital-associated pathogens to the community. We used two
published datasets from the US and Ireland to investigate the effects of hospital size and controlled for several confounders
such as antimicrobial usage, sampling frequency, mortality, disinfection and length of stay. The proportion of patients
acquiring both sensitive and resistant infections in a hospital strongly correlated with hospital size. Moreover, we observe
the same pattern for both the percentage of resistant infections and the increase of hospital-acquired infections over time.
One interpretation of this pattern is that chance effects in small hospitals impede the spread of drug-resistance. To
investigate to what extent the size distribution of hospitals can directly affect the prevalence of antibiotic resistance, we use
a stochastic epidemiological model describing the spread of drug resistance in a hospital setting as well as the interaction
between one or several hospitals and the community. We show that the level of drug resistance typically increases with
population size: In small hospitals chance effects cause large fluctuations in pathogen population size or even extinctions,
both of which impede the acquisition and spread of drug resistance. Finally, we show that indirect transmission via
environmental reservoirs can reduce the effect of hospital size because the slow turnover in the environment can prevent
extinction of resistant strains. This implies that reducing environmental transmission is especially important in small
hospitals, because such a reduction not only reduces overall transmission but might also facilitate the extinction of resistant
strains. Overall, our study shows that the distribution of hospital sizes is a crucial factor for the spread of drug resistance.
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Introduction
The last decades have shown that the introduction of an
antibiotic agent is almost inevitably followed by the spread of
resistance mutations that jeopardize the beneficial effect of this
agent [1,2]. Because of this process of bacterial adaptation to
antibiotics, maintaining the benefits of antibiotic therapy requires
a steady development of new drugs or drug classes. Population
biological models may contribute to slowing down the required
pace of this ‘‘drug treadmill’’ by identifying the factors that
determine the adaptability of bacterial populations to antimicro-
bial treatment [3].
The epidemic spread of antibiotic resistance can be strongly
affected by the structure of the human host population[4]. One of
the most important instances of such population structure is the
interaction between the hospital and the community[4]. These two
settings differ with respect to several parameters that are crucial for
the spread of antibiotic resistance. While the hospital environment
is characterized by small population sizes, high transmission rates,
fast turn over and frequent use of antibiotics, the community
exhibits comparatively large population sizes, small transmission
rates, slow turn-over rates and infrequent use of antibiotics.
Hospitals are often the source of emergent resistant strains [5], but
this spread is not unidirectional, as illustrated by outbreaks of
community-acquired MRSA in health care facilities [6]. Since the
spread of resistance mutations [7] increases with antibiotic usage
[8], the difference in treatment frequencies may explain why
hospitals mostly act as source for resistance mutations and the
community acts as a sink.
The size distribution of hospitals is an important determinant
for the population structure generated through the hospital-
community interaction. In small hospitals, bacterial population
sizes and frequencies are subject to strong stochastic effects and
populations may frequently become extinct. It has been empiri-
cally shown that resistance levels tend to be lower in small hospitals
[9,10,11,12,13]. In principle, this can be due to two reasons: On
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types of patients and treatments (i.e. lower antibiotic usage [14]),
which select for less resistance. On the other hand, small hospital
size by itself might hinder bacterial adaptation and thereby reduce
resistance levels. The fact that the analysis in [10] controlled for
patient characteristics, suggests that, at least in that case, the
impact of hospital size was due to the second ‘‘intrinsic’’
mechanism. In this study we use a simple population biological
model to analyze the intrinsic effects of hospital size, i.e. we assess
to what extent the stochastic effects resulting from small hospital
populations may help in alleviating the burden of antibiotic
resistance.
Methods
The model presented here extends the basic models for the
spread of antibiotic resistance [15,16] to a setting in which several
hospitals interact with the community. The flowchart in figure 1
shows the model in the simplest case (one hospital and one
community). More complicated structures of communities and
hospitals are illustrated in figure 2. The code was implemented in
the programming language C, the statistical programming
package R was used for the graphical representation of the results.
The parameters used and the corresponding references are listed
in table 1. As hospitals are often characterized by small population
sizes, we describe populations stochastically. Specifically, we use
the tau-leap approximation [17] of the Gillespie algorithm [18] to
implement stochasticity. The host-population is compartmental-
ized according to location (community, hospital 1, hospital 2, …,
hospital n) and colonization status (uncolonized; colonized with
sensitive strain; colonized with resistant strain). The model
includes the following processes:
N Admission & Discharge: Hospitals are characterized by the
turnover-rate of patients (rTurn), the expected patient popula-
tion size for which the hospital has been conceived (number of
beds)(SH) and the actual number of patients at a given time
point (NH). Admission and discharge events occur at rates SH
rTurn and NH rTurn, respectively, so that SH corresponds to the
average number of patients. At an admission event a randomly
chosen patient from the community enters the hospital and at
a discharge event a randomly chosen patient leaves the
hospital and reenters the community. We assume that the
colonization status does not affect the admission or discharge
rates. This is a reasonable approximation for many endoge-
nous infections, where organisms that are usually part of the
commensal microflora enter previously sterile body compart-
ments.
N Colonization: Uncolonized patients in the hospital and the
community become colonized with strain i (here and below i
can be either i=sfor the sensitive or i=rfor the resistant
strain) with a rate NH,i bH (1-si) and NC,i bC (1-s i), respectively.
Here NH,I (NC,i) denotes the number of patients in the hospital
(community) infected with strain i, bH (bC) denotes the
transmission rate in the hospital (community), and si the
fitness costs of the mutations carried by strain i (i.e. si is equal to
0 for the sensitive strain and equal to the cost of resistance for
the resistant strain).
N Clearance: In the hospital, patients colonized with strain i are
cleared with a rate rBaseline+uH if strain i is susceptible and with a
rate rBaseline is strain i is resistant. Here, rBaseline denotes the
baseline clearance and uH the usage frequency of the antibiotic
in the hospital. For the community, clearance rates are
obtained by substituting the usage frequency in the hospital by
the usage frequency in the community (uC).
N Mutation: A mutation from a strain i to a strain j becomes fixed
in a patient if it increases replicative fitness, i.e. if it either
confers resistance in a treated patient or a growth advantage in
an untreated patient. In the first case the mutation occurs with
a rate NH,j m uH and in the second case it occurs with a rate NH,j
m (si -sj) for the hospital and analogously for the community.
Each simulation run consists of a burn-in period followed by a
treatment period. In the burn-in period, the model is simulated for
30 years in absence of treatment (in order to reach the treatment-
free equilibrium, which typically consists in the absence of resistant
strains). In the treatment period, antibiotic usage frequencies (uH,
uC) increase linearly in the first five years until they reach their final
value, which is kept constant for the remaining 25 years of the
treatment period. In the following, values given for antibiotic
usage frequencies always refer to this final value.
Environmental transmission
Environmental transmission in the hospital can be added to the
above model via two additional, deterministic compartments
corresponding to the sensitive and resistant strain: the density of
bacteria of strain i in the environment, denoted Ei. Bacteria of
strain i colonize the environment with a rate NH,i cE and are
cleared from the environment at a constant rate rTurn,E. Bacteria
of strain i from the environment can in turn infect susceptible
patients with a force of infection bE Ei.. Because the total number
of bacteria in the environment is presumably very large and the
dynamics of the environmental compartment are not directly
affected by the fluctuations in the patient population, we assume
that this compartment can be adequately described deterministi-
cally.
Results
In this study we consider the effect of hospital size distribution
on the epidemic spread of antibiotic resistance. Specifically, we
Author Summary
The increasing spread of bacteria, which are resistant to
antibiotics, is a serious threat to clinical care. Currently,
several countries aim at concentrating highly specialized
services in large hospitals in order to improve patient
outcomes. However, empirical studies have shown that
resistance levels correlate with hospital size. To illustrate
this correlation, we analyze two published datasets from
the US and Ireland and controlled for antimicrobial usage,
disinfection and length of stay. The proportion of patients
acquiring both sensitive and resistant infections in
hospitals strongly correlated with hospital size. Moreover,
we observe the same pattern for both the percentage of
resistant infections and the temporal increase of hospital-
acquired infections. To investigate to what extent hospital
size can directly affect the prevalence of antibiotic
resistance, we use mathematical models describing the
epidemic spread of resistance in hospitals and the
community. We find that small hospitals typically lead to
considerably lower resistance levels than large hospitals.
However, this beneficial effect of small hospital size may
be reduced if bacteria are transmitted indirectly via the
environment. Therefore, reducing environmental transmis-
sion might be particularly important in small hospitals.
Overall, our findings suggest that the short-term benefits
of larger hospitals may come at the price of increasing
resistance in the long term.
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minimization, it is preferable to have a small number of large
hospitals or a large number of small hospitals. The focus of this
study is the theoretical assessment of resistance spread in hospitals
of different sizes. We start however with an analysis of two
published surveillance datasets from the US and Ireland to
illustrate the correlation between hospital size and acquisition rates
of both sensitive and resistant strains.
Analysis of surveillance data
We used an Irish surveillance dataset published by the Health
Service Executive Ireland [19] to investigate to what extent the
incidence of infections, especially by resistant strains, correlates
with hospital size. This dataset contains information from 53
hospitals about both the total number of new infections with S.
aureus as well as infections with MRSA (all positive blood-
cultures were recorded). Additionally reported quantities were:
length of stay, total inpatient antibiotic usage, injectable inpatient
antibiotic usage, the usage of hospital-specific antibiotics,
consumption of alcohol hand-gel and the frequency of blood
cultures per admission. We found a significant correlation
between the number of patient days/year (which is a proxy for
hospital size), and the rate of both total (figure 3A) and resistant
(figure 3C) S. aureus acquisitions, as well as the percentage of
methicillin-resistant isolates among all S. aureus positive blood
cultures (see figure 3E). This correlation remained significant
even when controlling for all the above-mentioned variables
(figure 3B,D,F). In the minimum adequate model chosen on the
basis of the Akaike information criterion (as implemented in the
function step(lm()) in R), hospital size was the parameter which
overall had the most significant impact. Unsurprisingly, the
amount of overall antibiotic usage also strongly correlated with
both absolute and relative resistance levels. Nevertheless, the
model fits (Figure 3) suggest that the impact of hospital size on
resistance level is at least of similar magnitude than the impact of
antibiotics consumption.
Figure 1. Flow chart of compartmental model in the simplest case (only one hospital and one community).
doi:10.1371/journal.ppat.1001334.g001
Figure 2. Illustration of the panmictic and subdivided population structures. Illustration of the models with panmictic (A) and subdivided
(B) community.
doi:10.1371/journal.ppat.1001334.g002
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Parameter Name Explanation Default Value
T Observation period over which results are averaged 30*365 d
EH Number of beds of one hospital 10–500
EC Size of community 300*Total Hospital Size#
bH transmission rate in hospital 0.4 d
21/Number of Beds
bC transmission rate in community 0.005 d
21/Size of community
s cost of drug resistance 10% –30% [28,29,30]
m Mutation rate 10
23 d
21
rTurn Turn-over rate of patients in hospital (i.e. discharge rate) 1/7 d
21##
rBaseline Baseline clearance rate 1/300 d
21 [32]
uH Frequency of antibiotic use in hospital 0.005–0.5 [33]
uC Frequency of antibiotic use in the community 10
24–0.02 [34]
Extension with environmental transmission in the hospital
cE Colonization rate of environment 1/10
rTurn,E Turn-over rate of environment 1/30 [22]
bE Transmission rate from environment bH* rTurn,E/cE
Extension with inter-ward transfer
w Inter-ward transfer rate 0.01–0.1/patient day [23]
# Global average number of hospital beds per inhabitant, as retrieved from the WHO database http://apps.who.int/ghodata/.
## The average length of stay is 8 days in Switzerland (http://www.obsandaten.ch/indikatoren/5_4_1/2005/d/541.pdf, data from 2005) and 5 days in the US (http://
www.cdc.gov/mmwr/preview/mmwrhtml/mm5427a6.htm).
doi:10.1371/journal.ppat.1001334.t001
Figure 3. Correlations between hospital size and incidence rates or resistance in Ireland 2006–2007. Size= Patient days/year; inpatient
DDD= Mean defined daily doses given to inpatients per 100 patient days; hosp-spec AB= Mean defined daily doses of hospital specific antibiotics/100
patient days; in. AB= Mean defined daily doses of injectable antibiotics/100 patient days; alc-gel= Mean consumption of alcohol-based hand gels in L/
1000 patient days; BC/admission= Mean number of bloodcultures per 1000 admissions. A) Mean total incidence rate of blood cultures positive for S.
aureus as a function of hospital size, the line represents the univariate linear model of incidence rate against hospital size B) Minimum adequate
model explaining the total incidence rate C) Mean incidence rate of blood cultures positive for methicillin-resistant S. aureus (MRSA) as a function of
hospital size, the line represents the univariate linear model of incidence rate against hospital size D) Minimum adequate model explaining the
incidence rate of MRSA E) Mean percentage of MRSA among all S. aureus bloodstream isolates F) Minimum adequate model explaining the
percentage of methicillin-resistant infections as a function of hospital size, the line represents the univariate linear model of percent resistant isolates
against hospital size.
doi:10.1371/journal.ppat.1001334.g003
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events, the same should generally be true for the total incidence
of hospital-acquired infections (although to a lesser degree, since
the number of total infections is always higher than the one of
resistant infections). To test our findings obtained with the Irish
dataset, we used surveillance data from the Pennsylvania Health
Care Cost Containment Council (PHC4) [20] to investigate in
how far infection rates are proportional to hospital sizes. In total,
149 Hospitals reported nosocomial infection rates (i.e. infections
that became symptomatic .48h after admission) quarterly from
2005 to 2007. Furthermore, mortality rates, mean length of stay
and infection rates by disease type (e.g. bloodstream infection or
pneumonia) were reported once per year. The median infection
rate throughout these 12 quarters strongly correlated with
hospital size (see figure 4A). This correlation remained very
strongly significant even when accounting for potential con-
founders such as length of stay, mortality or the number of
quarters in which electronic surveillance was used (see figure 4B).
In the minimum adequate model, the usage of electronic
surveillance also had a significant influence on infection rates
(see figure 3B). This is presumably because a higher fraction of
infections is reported with electronic surveillance. However, even
in this analysis the most significant effect (i.e. smallest p-value) on
resistance levels was due to hospital size. We observed that
infection rates and hospital size were significantly correlated in
any given year for the total infection rate as well as for the
infection rates of most types of infections (see table 2). Apart from
the average level of infection rates, one would also expect that the
temporal increase of infection rates would be smaller with
frequent extinction events. During the years 2005–2007, there
was a slight overall increase in infection rates (see figure 4C). For
each hospital, we fitted the total rate of acquiring infection with a
linear model with time and presence of electronic surveillance as
explanatory variables. If the change over the three years was not
significantly correlated to time, we set this change to zero. Also
the change in infection rates was significantly correlated to the
logarithm of the hospital size (see figure 4D).
Theoretical interpretation
We mainly consider two simple settings (see Figure 2), in which
hospitals of equal size are linked to a community, which is either
panmictic or strongly subdivided. In the case of a subdivided
community, we allow for migration between the sub-communities
(migration rate between 1%/year and 20%/year). These two
settings can be considered as models of the population structure in
urban and rural environments respectively. In either case we
assume that the number of hospital beds per inhabitant (i.e. the
fraction between the total hospital size and the community size)
is constant. Specifically, we consider a community of 3*10
5
individuals with 1000 hospital beds.
We find that, if drug use is high in the hospital and low in the
community, the level of resistance increases with hospital size
(Figure 5). This effect is even more pronounced if the community
is subdivided as well. However, substructure in the community
only seems to have a minor impact compared to the population
structure of hospitals (Figure 5). This makes sense intuitively as
population sizes in the community are much larger and hence
stochastic effects are comparatively weak. The pattern in figure 5
represents the typical situation for a nosocomial pathogen where
treatment rates are high in the hospital but low in the community.
In the following we generalize this pattern to a broad range of
Figure 4. Correlations between hospital size and incidence rates and their increase in Pennsylvania 2005–2007. A) Median quarterly
incidence rate of nosocomial (.48h after admission) infections as a function of hospital size, the line represents the univariate linear model of
incidence rate against hospital size B) Minimum adequate model explaining the incidence rate of nosocomial infections C) Quarterly incidence rates
of noscomial infections in Pennsylvania 2005–2007 D) Change in incidence rates from 2005–2007. Here, a linear model was fitted to the quarterly
incidence rates for each hospital. For each hospital, the slope of this regression (controlled for the introduction of electronic surveillance) was plotted
against the number of patient days per year. In order to determine the correlation between the change in incidence rates and hospital size, the slopes
were set to zero if there was no significant trend during the observed period.
doi:10.1371/journal.ppat.1001334.g004
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community, which as Figure 5 suggests represents the conservative
scenario concerning the effect of population size, and then
consider the additional effects conferred by substructures in the
community.
Effects of hospital size in a panmictic community. When
varying the usage frequencies of antibiotics, we find three basic
effects (Figure 6A): 1) Reducing hospital size leads to a substantial
reduction of resistance prevalence if the antibiotic is deployed
frequently in the hospital but infrequently in the community. 2)
This beneficial effect of small hospital size decreases in magnitude
if drug-use in the hospital is too large (upper left corner in
Figure 6A, B and C). 3) Contrary to the pattern in figure 5, small
hospital size might lead to an increase in the level of resistance if
antibiotic usage frequencies are of similar magnitude in both the
hospital and the community. The effects 1–3 also occur for
different fitness costs (Figure 6A–C), although the exact usage
frequencies at which they occur shifts.
These effects and the parameter combinations at which they
occur can be understood as follows: If antibiotic usage is low in
the community and high in the hospital, selection acts strongly
against antibiotic resistance in the community and in favor of
antibiotic resistance in the hospital. In this case, frequent
extinctions in the hospital, caused by a small population size,
weaken the resistance-favoring selection in the hospital compared
to the resistance-disfavoring selection in the community. This
occurs because, when the resistant strain is extinct in the hospital,
selection has no diversity to act on and is therefore ineffec-
tive[21]. Hence, with decreasing hospital size, resistance occurs at
lower levels (Effect 1). Since the hospital acts as a source for the
drug resistance mutations in the community, the prevalence of
drug resistance in the community increases with increasing drug
usage in the hospital. Thus, if drug usage in the hospital is too
large then drug resistance becomes frequent in the community.
This in turn impedes extinctions in the hospital through frequent
reintroduction of resistant strains and accordingly reduces the
impact of hospital size (Effect 2). Finally, Effect 3 can be
understood as the inversion of Effect 1, which occurs when
resistance is selected against in the hospital and selected for in the
community (see below).
In this context it is important to note that, because of different
turnover rates, a level of drug usage that would lead to selection
against drug resistance in the hospital can lead to selection for drug
resistance in the community. Selection in the hospital or the
community on its own, favors resistance if the fitness of the
resistant strain (R0’) exceeds the fitness of the sensitive strain (R0).
The ratio of these fitnesses is given by
Table 2. Correlation between hospital size and type of infection for each given year from 2005–2007.
2005 2006 2007
R
2 slope p-value R
2 slope p-value R
2 slope p-value
Total Infections 0.3 7.1 1610
214 (***) 0.4 11.4 4610
220 (***) 0.41 9.7 8610
221 (***)
Urinary Tract 0.22 4.0 7610
211 (***) 0.34 5.4 2610
216 (***) 0.28 4.4 2610
213 (***)
Urinary Tract (device-associated) no data 0.29 4.0 6610
214 (***) 0.32 3.4 2610
215 (***)
Urinary Tract (nondevice-associated) no data 0.12 1.4 4610
206 (***) 0.05 1.0 0.0032 (**)
Pneumonia 0.03 0.4 0.0088 (**) 0.02 0.5 0.0579 0.08 0.8 0.0001 (***)
Pneumonia (device-associated) no data 0 20.2 0.2374 0.05 0.2 0.0024 (**)
Pneumonia (nondevice-associated) no data 0.06 0.7 0.0009 (***) 0.05 0.6 0.0029 (**)
Bloodstream 0.17 1.3 2610
208 (***) 0.22 1.4 1610
210 (***) 0.22 1.1 1610
210 (***)
Bloodstream (device-associated) no data 0.13 0.9 7610
207 (***) 0.12 0.6 3610
206 (***)
Bloodstream (nondevice-associated) no data 0.18 0.5 5610
209 (***) 0.18 0.5 8610
209 (***)
Surgical Site 0 1.0 0.249 20.01 0.3 0.6918 0 20.4 0.5343
Gastrointestinal no data 0.13 1.7 9610
207 (***) 0.18 1.4 1610
208 (***)
Other Infections no data 0.03 0.2 0.0132 (*) 0.02 0.2 0.0524
Multiple 0.09 0.9 7610
205 (***) 0.24 1.9 2610
211 (***) 0.27 1.5 3610
213 (***)
*p,0.05,
**p,0.01,
***p,0.001
doi:10.1371/journal.ppat.1001334.t002
Figure 5. The effect of hospital size. Prevalence of resistance in the
hospital for hospitals of different sizes linked to a subdivided (dashed
lines) or panmictic community (dots). Antibiotic usage frequency is high
in the hospital (uH= 0.1), but low in the community (uC = 0.0001). For
the subdivided community the rate of migration between sub-
communities is 5%/year. Each point corresponds to the average over
1000 simulations.
doi:10.1371/journal.ppat.1001334.g005
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where b (b’) denotes the transmission rate of the sensitive (resistant
strain), t the turnover of infections in the setting considered, s the
fitness cost of drug resistance, and u the usage frequency of the
antibiotic. It follows that resistance is selected (i.e. R0’/R0.1) if the
usage frequency is above a threshold given by t
s
1{s
. As the
turnover in the hospital is much larger than the turnover in the
community (here 1/7 d
21 vs. 1/300 d
21) the same applies to these
thresholds and hence resistance becomes selected for at much lower
usage frequencies in the community than in the hospital. The white
lines in Figure 6 correspond to these threshold values and show that
these thresholds can indeed largely explain the patterns 1 and 3.
Additional effects of substructures in the community. If
the community is subdivided as well, the beneficial effects of small
hospital size are increased further (Figure 7). This is because, in most
sub-communities, no resistant strains preexist when therapy is
initiated. If in such a situation treatment frequencies are high
enough, the entire bacterial population (i.e. all colonized individuals)
in such a sub-community and the associated hospital might become
extinct before the first resistant strain appears through mutation. In
such a sub-community, all individuals will remain uncolonized until
it acquires a resistant strain through migration from an other sub-
community. Accordingly the additional effect conferred by
substructures in the community strongly decreases as the migration
rate between sub-communities increases (Figure 7b and c).
Effect of an environmental reservoir. Nosocomial
infections do not only spread by direct (patient-to-patient)
transmission but also by indirect transmission via the environment
(beds, doorknobs etc.). Hospitals exhibit a high turnover of patients
and hence in the absence of influx or transmission, the number of
infections decays rapidly and eventually the pathogen may become
extinct. By contrast, the environment can potentially act as a
reservoir [22] and thereby prevent extinctions. According to our
above finding that small hospitals impede resistance evolution
Figure 6. Relative change of resistance-prevalence in small vs. large hospitals linked to a panmictic community. The relative change in
resistance-prevalence is measured as
average prevalence for hospitals of size 20
average prevalence for hospitals of size 100
{1 and is plotted as a function of the frequency of drug-use in the
hospital and the community. Panels correspond to different costs of drug resistance: s=0.1 (A), s=0.2 (B), s=0.3 (C). The resistance prevalence for
each parameter combination has been computed as the average over 500 simulations. The white lines correspond to the threshold values when R0 of
the resistant strain becomes higher than R0 of the wild-type strain in the hospital (horizontal) and the community (vertical).
doi:10.1371/journal.ppat.1001334.g006
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of environmental transmission should reduce this effect of hospital
size. Indeed, we find that the addition of an environmental reservoir
can considerably diminish the benefits of small hospital size.
However, even in the presence of a reservoir, small hospitals can
slightly reduce the burden of antibiotic resistance for many
parameter settings (figure 8).
Effect of ward structure and intra-hospital transfer. Up
to this point we have approximated the patient population in a
given hospital as panmictic; i.e. we have assumed that the
transmission probability is the same for all pairs of patients.
Hospitals, however, often exhibit strong population structure
imposed by hospital wards. The opposite extreme of the panmictic
hospital model considered so far is a hospital model consisting of
completely subdivided hospital wards. This latter extreme is
formally identical to a model in which every ward of a given size is
replaced by hospital of the same size. The population structure of
real hospitals most likely lies between these extremes: it is
characterized by ward structure but also by frequent migration
between wards. For instance Leverstein-VanHall et al. found, for
patients infected with resistant strains, interward migration rates of
0.03–0.07 per patient-day[23]. We assessed this setting by
comparing (as previously) the level of resistance in large hospitals
(10 hospitals of 100 beds each) and in small hospitals (20 beds).
Here, the large hospitals are subdivided into wards of 20 beds with
inter-ward migration rates chosen between 0.01 and 0.1 per
patient-day. With this model we find that on the one hand the
disadvantage of large hospitals can be compensated in part by
imposing a ward structure, but on the other hand we still find a
substantial difference between large and small hospitals for realistic
migration rates (see Figure 9).
Discussion
It has been argued that concentrating highly specialized
services in large hospitals will both improve patient outcomes
as well as reduce health care costs [24,25,26,27]. Yet, larger
hospitals may have their own disadvantages by facilitating the
spread of infectious diseases and resistance genes [10]. We used
two surveillance datasets from the US [20] and Ireland [19] to
Figure 7. Relative change of resistance-prevalence in small vs. large hospitals linked to a subdivided community. The relative change
in resistance-prevalence is measured as
average prevalence for hospitals of size 20
average prevalence for hospitals of size 100
{1 and is plotted as a function of the frequency of drug-use in
the hospital and the community. Panels correspond to different migration rates between sub-communities: m=1%/year (A), m=5%/year (B),
m=20%/year (C). The cost of resistance was set to 0.2 (corresponding to Figure 6B). The resistance prevalence for each parameter combination has
been computed as the average over 500 simulations.
doi:10.1371/journal.ppat.1001334.g007
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on hospital size. In line with the results of Bhavnani et al. [10], we
found that the rates of acquiring both resistant infections and
infections in general strongly and significantly correlated with
patient-days/year (hospital size). Furthermore, the increase of
total infections over time and the ratio of resistant and drug-
sensitive infections also significantly correlated with hospital size.
Of course, different patient populations in small and large
hospitals could also explain such a pattern. Antibiotic consump-
tion and morbidity (and thereby susceptibility to infections) might
be much higher in larger hospitals caring for more severely ill
patients. However, this would not explain the steeper rise of
infections in large hospitals. Additionally, the correlations
between hospital size and incidence levels persisted even when
taking the following potentially confounding factors into account:
mortality, length of stay, antibiotic usage, usage of injectable or
hospital-specific antibiotics, sampling frequency, or the usage of
disinfectants. Both datasets analyzed have both problems and
advantages. In the dataset from Ireland, for example, only S.
aureus was considered, all positive blood cultures were recorded
(even those which might have been acquired outside the given
hospital) and there are no data on mortality. Conversely, the
dataset from the US does not include the drug-sensitivity of the
infections, drug usage or disinfection. However, these drawbacks
do not overlap, and our results are coherent for both datasets.
This makes it somewhat less likely that such confounders are the
only reason for the correlation of resistance with hospital size.
Furthermore, hospital size had a more significant impact than
antibiotic usage on both relative prevalence and absolute
incidence rates of methicillin-resistant S. aureus. Reducing
antibiotic consumption is a common recommendation for
curbing the spread of resistance. The analyzed data suggest that
a reduction in hospital size might therefore be a similarly
successful intervention.
We used a stochastic epidemiological model in order to describe
both the spread of drug resistance in a hospital setting as well as
the interaction between one or several hospitals and the
community. Like all theoretical models, this is a very simplified
description of complex interactions. For example, the epidemio-
logical fitness costs of resistance are inherently difficult to
determine. We used estimates of the epidemiological costs of
resistance in tuberculosis [28] and of glycopeptide resistance in
farm animals [29] as well as in vitro data [30] as guidelines,
because no estimates on the transmissibility of resistant nosocomial
Figure 8. Relative change of resistance-prevalence in small vs. large hospitals with environmental transmission in the hospital.
Same as Figure 6 but with environmental transmission in the hospital. Specifically, 50% of the force of infection in the hospital is mediated via the
environmental reservoir. Panels correspond to different costs of drug resistance: s=0.1 (A), s=0.2 (B), s=0.3 (C).
doi:10.1371/journal.ppat.1001334.g008
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co-infection, whereas in reality patients may harbor both resistant
and sensitive strains, such that sufficiently long after discontinu-
ation of antibiotic therapy the sensitive strains could dominate
again. This effect can, however, be captured in our model by
increasing the back-mutation rate (i.e. the rate with which a
patient that is predominantly infected with the resistant strain
becomes dominated by the sensitive strain in the absence of
therapy). We find that increasing this rate substantially increases
the magnitude of the effect of hospital size (results not shown).
Intuitively, this is the case because with a higher reversion rate the
level of resistance in the community (the ‘‘sink’’) declines.
Therefore it becomes less likely that the resistant strain is
reintroduced from the community once it becomes extinct in a
hospital. Thus, the assumption made here leads to rather
conservative estimates for the effect of hospital size. In summary,
the results from our theoretical model should be regarded as
qualitative descriptions, not as quantitative predictions on how
much resistance could be reduced if hospitals were smaller.
Theoretically, the impact of hospital size on the evolution of
antibiotic resistance can be explained by the meta-population
dynamics characterized by local extinctions and re-colonizations.
According to this interpretation, the beneficial effect of small
hospital size is the result of a simple evolutionary mechanism:
Selection typically acts in different directions in the hospital and in
the community: resistance is selected for in the hospital and
selected against in the community. Thus any mechanism, which
weakens the effectiveness of selection in the hospital relative to that
in community, will lead to an increase in the level of resistance.
According to Fisher’s fundamental theorem, the effectiveness of
selection acting on a trait (here trait = resistance) is proportional
to the variance in that trait. Small hospital size decreases the
variance in resistance through frequent extinctions of the
resistance-conferring allele. In other words, if the resistance-
conferring allele is extinct in a given hospital, selection (which
would potentially favor this allele) is completely ineffective because
the population consists only of the sensitive strain and selection can
only favor one strain over the other if they coexist. In addition to
the hospital-community setting described here, many more
instances of population structure might cause similar meta-
population effects that hinder the epidemic spread of antibiotic
resistance mutations. Indeed, we made the same observations
when considering inter-ward transfer. Further examples include:
household structure, caring facilities, schools etc. Thus the effects
described here are likely to extend beyond the hospital-community
setting.
Figure 9. Relative change of resistance-prevalence in small vs. large subdivided hospitals. Same as Figure 6B, but assuming that the large
hospital (size 100) is subdivided into 5 wards of 20 twenty with different transfer rate between wards (A: 0.01), (B: 0.05), (C: 0.1).
doi:10.1371/journal.ppat.1001334.g009
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given size, the magnitude of stochastic effects will typically be
considerably stronger than what might be expected from a simple
population-biological model like the one presented here. The
reason for this is that several processes such as population
structure, fluctuating population sizes, and variability in transmis-
sion rates (e.g. super-spreaders) strongly enhance stochasticity.
Thus, a real hospital with a given number of patients will typically
behave like an idealized hospital, which is much smaller. (This
type of problem is well known in population genetics [31], and as a
consequence populations are often characterized by a so-called
effective population size rather than by their census population
size). Nevertheless, all other things being equal, a small hospital
will be subject to stronger stochastic effects than a large hospital
and will hence suffer less from antibiotic resistance.
In contrast to the typical beneficial effect of small hospital size,
we also found that under some circumstances small hospitals may
increase the prevalence of antibiotic resistance. This effect occurs if
antibiotic usage in the community reaches similar magnitude than
in the hospital. Such a setting might be uncommon for nosocomial
infections, which are mainly treated in the hospital. However, it
might occur for other infections, which occur frequently in both
the hospital and the community (e.g. E. Coli causes many
opportunistic infections in the hospital and urinary tract infections
in the community).
Overall, the results of this study suggest the general pattern that
strong population subdivision in those compartments, where
antibiotic usage is high (typically: the hospital), can substantially
reduce the spread of antibiotic resistance. Furthermore, we find
that this beneficial effect of small hospital-size is substantially
reduced if a substantial fraction of infection events is not acquired
directly from other patients (which exhibit a fast turnover in the
hospital), but, indirectly, via a slowly decaying environmental
compartment. This latter point indicates that reducing such
environmental transmission might be especially important in small
hospitals as this might not only reduce the force of infection but
also the burden of antibiotic resistance by promoting the stochastic
extinction of resistant pathogen strains.
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